View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Endocrinology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 25, 2024
3 min read
Save

Q&A: New initiative to address CKM syndrome, affecting millions in the US

Q&A: New initiative to address CKM syndrome, affecting millions in the US

In October 2023, the American Heart Association unveiled the term cardiovascular-kidney-metabolic syndrome to reflect the connection between metabolic and renal conditions associated with risk for heart disease.

SPONSORED CONTENT
July 25, 2024
1 min read
Save

Voluntary medical device correction issued for small subset of FreeStyle Libre 3 sensors

Voluntary medical device correction issued for small subset of FreeStyle Libre 3 sensors

A voluntary medical device correction has been issued for a small number of continuous glucose monitoring sensors distributed in the first half of May, according to an industry press release.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
July 25, 2024
3 min read
Save

Postprandial insulin may cut hypoglycemia rates for hospitalized adults with diabetes

Postprandial insulin may cut hypoglycemia rates for hospitalized adults with diabetes

Changing in-hospital nutritional insulin administration from before meals to after meals lowered hypoglycemia rates at a community hospital, according to study findings published in Diabetes Research and Clinical Practice.

SPONSORED CONTENT
July 24, 2024
2 min read
Save

Gastric bypass for obesity lowers major atherogenic blood lipids vs. very low-energy diet

Gastric bypass for obesity lowers major atherogenic blood lipids vs. very low-energy diet

Patients with severe obesity undergoing Roux-en-Y gastric bypass for weight loss demonstrated greater reductions in blood lipids at 6 weeks vs. those on a very low-energy diet, according to study results in JAMA Surgery.

SPONSORED CONTENT
July 24, 2024
2 min read
Save

Immunotherapy to treat early-stage type 1 diabetes receives FDA fast track designation

Immunotherapy to treat early-stage type 1 diabetes receives FDA fast track designation

An immunotherapy to treat type 1 diabetes for people with the human leukocyte antigen DR3-DQ2 genotype received its second fast-track designation from the FDA, according to a company press release.

SPONSORED CONTENT
July 24, 2024
3 min read
Save

Risk for heart, liver disease may vary between PCOS subtypes

Risk for heart, liver disease may vary between PCOS subtypes

Women with polycystic ovary syndrome and high androgen levels may have a higher risk for liver disease than those with PCOS and normal androgen levels, according to an analysis of UK Biobank data.

SPONSORED CONTENT
July 23, 2024
2 min read
Save

Child-onset diabetes linked to high risk for mental health disorders later in life

Child-onset diabetes linked to high risk for mental health disorders later in life

Individuals who develop type 1 diabetes during childhood experienced greater risk for several mental health conditions later in life, including anxiety disorders and substance use disorders, study results showed.

SPONSORED CONTENT
July 23, 2024
2 min read
Save

GLP-1 receptor agonist prescriptions for obesity have risen in those without diabetes

GLP-1 receptor agonist prescriptions for obesity have risen in those without diabetes

New prescriptions of GLP-1 receptor agonists for the treatment of obesity have increased significantly among individuals without type 2 diabetes in the last decade, according to a study in Annals of Internal Medicine.

SPONSORED CONTENT
July 23, 2024
1 min read
Save

Weight-loss surgery appears to benefit patients with heart failure, obesity

Weight-loss surgery appears to benefit patients with heart failure, obesity

In a single-center cohort of patients with heart failure and obesity, weight-loss surgery led to improved clinical outcomes including reduced BMI and HbA1c and less reliance on diuretics, researchers reported.

SPONSORED CONTENT
July 23, 2024
2 min read
Save

Semaglutide does not raise risk for neurologic disorders for adults with type 2 diabetes

Semaglutide does not raise risk for neurologic disorders for adults with type 2 diabetes

Semaglutide was not associated with increased risks for adverse neurologic or psychological disorders at 1 year compared with other diabetes drugs, according to data published in eClinicalMedicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails